Literature DB >> 21935296

Lurasidone HCl (Latuda), an Oral, Once-Daily Atypical Antipsychotic Agent for the Treatment of Patients with Schizophrenia.

Martin P Cruz.   

Abstract

Entities:  

Year:  2011        PMID： 21935296      PMCID： PMC3171824     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


× No keyword cloud information.
  10 in total

1.  Dimensional approach to delusions: comparison across types and diagnoses.

Authors:  P S Appelbaum; P C Robbins; L H Roth
Journal:  Am J Psychiatry       Date:  1999-12       Impact factor: 18.112

Review 2.  Outcome in schizophrenia: beyond symptom reduction.

Authors:  H Y Meltzer
Journal:  J Clin Psychiatry       Date:  1999       Impact factor: 4.384

3.  The economic burden of schizophrenia in the United States in 2002.

Authors:  Eric Q Wu; Howard G Birnbaum; Lizheng Shi; Daniel E Ball; Ronald C Kessler; Matthew Moulis; Jyoti Aggarwal
Journal:  J Clin Psychiatry       Date:  2005-09       Impact factor: 4.384

4.  Negative symptoms in schizophrenia. Definition and reliability.

Authors:  N C Andreasen
Journal:  Arch Gen Psychiatry       Date:  1982-07

5.  Neuropsychological function in schizophrenia. Selective impairment in memory and learning.

Authors:  A J Saykin; R C Gur; R E Gur; P D Mozley; L H Mozley; S M Resnick; D B Kester; P Stafiniak
Journal:  Arch Gen Psychiatry       Date:  1991-07

6.  The psychosis of schizophrenia: prevalence, response to atypical antipsychotics, and prediction of outcome.

Authors:  A Breier; P H Berg
Journal:  Biol Psychiatry       Date:  1999-08-01       Impact factor: 13.382

Review 7.  Atypical antipsychotics: mechanism of action.

Authors:  Philip Seeman
Journal:  Can J Psychiatry       Date:  2002-02       Impact factor: 4.356

8.  Five-factor model of schizophrenia. Initial validation.

Authors:  J P Lindenmayer; R Bernstein-Hyman; S Grochowski
Journal:  J Nerv Ment Dis       Date:  1994-11       Impact factor: 2.254

9.  Dimensions of schizophrenic positive symptoms: an exploratory factor analysis investigation.

Authors:  T Kitamura; Y Okazaki; A Fujinawa; I Takayanagi; Y Kasahara
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1998       Impact factor: 5.270

Review 10.  Emotion recognition via facial expression and affective prosody in schizophrenia: a methodological review.

Authors:  Jane Edwards; Henry J Jackson; Philippa E Pattison
Journal:  Clin Psychol Rev       Date:  2002-07
  10 in total
  4 in total

Review 1.  Newer antipsychotics and upcoming molecules for schizophrenia.

Authors:  Melvin George; Radhika Amrutheshwar; Ravi Philip Rajkumar; Shivanand Kattimani; Steven Aibor Dkhar
Journal:  Eur J Clin Pharmacol       Date:  2013-04-02       Impact factor: 2.953

2.  Use of Antipsychotic Drugs During Pregnancy.

Authors:  Hannah K Betcher; Catalina Montiel; Crystal T Clark
Journal:  Curr Treat Options Psychiatry       Date:  2019-01-30

3.  A study of the structure-affinity relationship in SYA16263; is a D2 receptor interaction essential for inhibition of apormorphine-induced climbing behavior in mice?

Authors:  Edem K Onyameh; Barbara A Bricker; Suresh V K Eyunni; Chandrashekhar Voshavar; Uma M Gonela; Edward Ofori; Andrea Jenkins; Seth Y Ablordeppey
Journal:  Bioorg Med Chem       Date:  2020-12-14       Impact factor: 3.641

4.  Lurasidone-induced anemia: Is there a need for hematological monitoring?

Authors:  Vivek C Kirpekar; Abhijeet D Faye; Sudhir H Bhave; Rahul Tadke; Sushil Gawande
Journal:  Indian J Pharmacol       Date:  2019 Jul-Aug       Impact factor: 1.200
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.